跳至主要内容
临床试验/NCT06694194
NCT06694194已完成不适用

Global, Regional, and National Burdens and Trends of Tracheal, Bronchial, and Lung Cancer in Individuals Aged 70 Years and Older from 1990 to 2021

Hongquan Xing0 个研究点目标入组 111,627 人开始时间: 1990年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
111,627
主要终点
The incidence, mortality, and disability-adjusted life years (DALYs) data for TBL cancer patients aged ≥ 70 years, spanning 1990-2021.

研究概览

简要总结

Despite the increasing health burden of tracheal, bronchial, and lung (TBL) cancer patients aged ≥ 70 years worldwide, data on its burden and trends are limited. This study aimed to analyze the global, regional, and national burdens and trends of TBL cancer from 1990 to 2021.

详细描述

The latest cancer report indicates that tracheal, bronchial, and lung (TBL) cancer, the most widespread cancer globally, accounts for 12.4% of new diagnoses and 18.7% of cancer-related deaths, thereby presenting significant societal, public health, and economic challenges.Despite the increasing health burden of tracheal, bronchial, and lung (TBL) cancer patients aged ≥ 70 years worldwide, data on its burden and trends are limited. This study aimed to analyze the global, regional, and national burdens and trends of TBL cancer from 1990 to 2021.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Pathologic Diagnosis of lung cancer

排除标准

  • breast cancer Age less than 70 years

结局指标

主要结局

The incidence, mortality, and disability-adjusted life years (DALYs) data for TBL cancer patients aged ≥ 70 years, spanning 1990-2021.

时间窗: 1990-2021

We extracted the incidence, mortality, and disability-adjusted life years (DALYs) for TBL cancer in individuals aged ≥ 70 years and above along with their 95% uncertainty intervals (UIs) from the GBD 2021 database (https://vizhub.healthdata.org /gbd-results/). The data were stratified by age groups and social determinants of the health index (SDI) regions, encompassing 21 global GBD regions and 204 countries.

次要结局

未报告次要终点

研究者

发起方
Hongquan Xing
申办方类型
Other

相似试验